3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Weight Loss
6
Breast Neoplasms
6
Obesity
5
Motor Activity
5
Polycystic Ovary Syndrome
4
Neoplasms
4
Colorectal Neoplasms
3
Prostatic Neoplasms
2
Overweight
2
Multiple Endocrine Neoplasia Type 1
2
Endometrial Neoplasms
2
Colonic Neoplasms
2
Body Weight Changes
2
Urologic Neoplasms
1
Urinary Bladder Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Smoking Cessation
1
Sexual Dysfunction, Physiological
1
Polyps
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Menstruation Disturbances
1
Malnutrition
1
Lung Neoplasms
1
Inflammation
1
Infertility
1
Hypercholesterolemia
1
Gastrointestinal Neoplasms
1
Diabetes Mellitus, Type 2
1
Carcinoma, Intraductal, Noninfiltrating
1
Interventions
relacorilant
4
Resistance Training
3
Pioglitazone
3
Dipeptidyl-Peptidase IV Inhibitors
3
Sulfonylurea Compounds
2
Rosiglitazone
2
Nutritional Status
2
Metformin
2
voglibose
1
saxagliptin
1
repaglinide
1
pembrolizumab
1
miglitol
1
metahexamide
1
meglitinide
1
glymidine
1
glisoxepide
1
gliquidone
1
glimepiride
1
glibornuride
1
empagliflozin
1
Vildagliptin
1
Troglitazone
1
Tolbutamide
1
Tolazamide
1
Thiazolidinediones
1
Surveys and Questionnaires
1
Sodium-Glucose Transporter 2 Inhibitors
1
Sitagliptin Phosphate
1
Resistant Starch
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Diabetes Mellitus, Type 2
×
Diet
×
Clear all
NCT03206827
2021-09-27
ScenoProt
University of Helsinki
Phase NA
Completed
147 enrolled